Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens

BACKGROUND: With the introduction of integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART), persons living with HIV have a potent new treatment option. Recently, providers at our large treatment clinic noted weight gain in several patients switched from efavirenz/tenofovir d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Acquir Immune Defic Syndr
Hauptverfasser: Norwood, Jamison, Turner, Megan, Bofill, Carmen, Rebeiro, Peter, Shepherd, Bryan, Bebawy, Sally, Hulgan, Todd, Raffanti, Stephen, Haas, David W., Sterling, Timothy R., Koethe, John R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680113/
https://ncbi.nlm.nih.gov/pubmed/28825943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001525
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge